Last reviewed · How we verify

NCT05603091: POLAR-WAVE

Pressure Wave Guided Atrial Fibrillation Cryoablation

Status unknown Last updated 31 January 2023
What this trial tests

trial testing cryoablation of pulmonary veins in Atrial Fibrillation in 100 participants. Status unknown.

Timeline
19 October 2022
Primary endpoint
31 March 2024
30 June 2024

Quick facts

Lead sponsorHospital Universitario 12 de Octubre
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date19 October 2022
Primary completion31 March 2024
Estimated completion30 June 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Universitario 12 de Octubre

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective multicenter observational study evaluating the performance of pressure wave-guided atrial fibrillation cryoablation used in accordance with clinical practice guidelines.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Hospital Universitario 12 de Octubre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05603091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing